Dr. Li is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 Fifth Ave
Pittsburgh, PA 15213
Summary
- Infectious Diseases Physician at UPMC
Education & Training
- Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 2019 - 2021
- UPMC Medical EducationResidency, Internal Medicine, 2016 - 2019
- Peking Union Medical CollegeClass of 2015, MD
- Tsinghua UniversityPre-Medical education, 2007 - 2010
Certifications & Licensure
- PA State Medical License 2022 - 2026
- MA State Medical License 2019 - 2023
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Emerging-Generation Awards ASCI, 2024
- Maxwell Finland Award for Excellence in Research Massachusetts Infectious Diseases Society, 2022
- Young Investigator Scholarship CROI- International Antiviral Society–USA, 2021
- Join now to see all
Publications & Presentations
PubMed
- Senescence-related cytokine levels are associated with HIV-1 serostatus and persistence.Yijia Li, Zoamy N Soto-Ramirez, Jenny Roscher, Tom Medvec, Mounia Alaoui-El-Azher
Medrxiv. 2025-02-07 - Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance.Tin Phan, Ruy M Ribeiro, Gregory E Edelstein, Julie Boucau, Rockib Uddin
Journal of Virology. 2025-02-04 - Viral and immune predictors of HIV posttreatment control.Flavio S Mesquita, Yijia Li, Jonathan Z Li
Current Opinion in HIV and AIDS. 2025-01-01
Press Mentions
- High Nasal and Total SARS-CoV-2 RNA Levels Associated with Longer RecoveryNovember 9th, 2022
- Mass General Brigham Study Highlights Varied Risk of Persistent COVID-19 Infection Among Immunocompromised PatientsJanuary 25th, 2024
- Prolonged SARS-CoV-2 Risk Varies Across Immunosuppressive ConditionsFebruary 3rd, 2024
Professional Memberships
- IDSAMember
- IAS-USAMember
Other Languages
- Chinese (Mandarin)
External Links
- Google Scholarhttps://scholar.google.com/citations?hl=en&user=kK3wWigAAAAJ
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: